NCT04374604View on ClinicalTrials.gov

Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic Women

CompletedOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

July 22, 2019

Study Completion Date

July 31, 2019

Conditions

Pre-Eclampsia

Interventions

DIAGNOSTIC_TEST

Placental growth factor

On admission, the blood samples of consenting participants will be collected and analysed using enzyme linked immunosorbent assay technique to determine the level of PlGF (pg/ml).

Trial Locations (1)

840001

Alex Ekwuueme Federal University Teaching Hospital, Abakaliki

All Listed Sponsors

lead

Johnbosco Ifunanya Nwafor

OTHER

NCT04374604 - Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic Women | Biotech Hunter | Biotech Hunter